Clinical Trial Update: Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair [Phase 1, Phase 2]

View source ↗

Summary

A preliminary phase 1/2 study of CA-008 (Vocacapsaicin) in patients undergoing ventral hernia repair has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postsurgical Pain
• Ventral Hernia

Drugs mentioned

• CA-008 (Vocacapsaicin) (vocacapsaicin)

Snippet

Sponsor: Concentric Analgesics | Conditions: Postsurgical Pain | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-09-14